Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

Medical Devices & Biomaterials
Filter     Order     Display # 
Date Item Title
10 Oct 2006 Medtronic Receives FDA Approval To Study Infuse Bone Graft In The Cervical Spine
05 Oct 2006 Ondine Biopharma Announces Results from Clinical Trial
03 Oct 2006 Genzyme Receives European Approval for Synvisc® In Ankle and Shoulder Osteoarthritis Indications
28 Sep 2006 Kensey Nash Announces 510(K) Clearance for Proprietary Bone Void Filler
19 Sep 2006 NuVasive Treats First Patient with NeoDisc(TM)
14 Sep 2006 Uroplasty, Inc. Receives FDA Approvable Letter For Macroplastique
14 Sep 2006 Vasogen’s Celacade™ Shown to Significantly Reduce Time in Hospital in Prime Heart Failure Target Population
12 Sep 2006 Recent Publication Shows Open Tibial Fracture Patients Have Improved Outcomes with Medtronic’s Infuse Bone Graft (rhBMP-2)
08 Sep 2006 SurModics and X-Cell Medical Collaborate on Drug Eluting Stent Development; Bravo(TM) Polymer Matrix Licensed for Delivery of 17 beta-Estradiol
07 Sep 2006 SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)
07 Sep 2006 FDA Grants Humanitarian Use Device Designation to Cyberkinetics' Andara(TM) OFS Device for Acute Spinal Cord Injuries; Designation Marks Critical Regulatory Step Toward Commercialization
06 Sep 2006 Abiomed Receives FDA Approval Of The Abiocor®, The World's First Completely Self-Contained, Implantable Artificial Heart
06 Sep 2006 Conor Medsystems Announces Two-Year Follow-Up Data from EuroSTAR Pivotal Study
06 Sep 2006 Cryocath Receives FDA Approval To Start AF Trial
06 Sep 2006 Study Results Point to Possible Application of Inovio's Electroporation-Based Therapy in Conjunction with Surgery to Treat Solid Tumor Margins
06 Sep 2006 Otologics Announces a Clinical Research Study for a New Fully Implantable Hearing Device
06 Sep 2006 OLYMPIA Phase I Registry Demonstrates Safety and Performance of TAXUS® Liberte™ Stent System in Complex Patients and Lesions
04 Sep 2006 Landmark European Trial Further Demonstrates that Cardiac Resynchronization Therapy (CRT) Reduces Morbidity and Mortality in Patients with Heart Failure
25 Aug 2006 BioSyntech receives approval for Canadian BST-DermOn(R) pivotal clinical trial
15 Aug 2006 Abbott Enrolls First Patient in New Clinical Trial Utilizing XIENCE(TM) V Drug Eluting Stent
12 Aug 2006 Genzyme Files for European Approval of Synvisc(R) In Ankle and Shoulder Indications
09 Aug 2006 Focus Surgery, Inc. Receives FDA Approval for a Phase III Clinical Study Using HIFU with the Sonablate(R) 500 for the Treatment of Prostate Cancer
09 Aug 2006 Antares Submits 510(k) with a Branded Human Growth Hormone
09 Aug 2006 FlowCardia, Inc. Completes Enrollment in the FACTOR Coronary Pivotal Study and Initiates the PATRIOT Peripheral Pivotal Study With the CROSSER(TM) CTO Recanalization System
07 Aug 2006 Collagen Matrix, Inc. Receives FDA 510(k) Clearance for Collagen Nerve Wrap
03 Aug 2006 Northstar Neuroscience Announces Feasibility Study of its Cortical Stimulation System for Treatment-Resistant Depression
01 Aug 2006 ADEPT offers Novel Fluid-Based Approach for Reducing Post-Surgical Adhesions
27 Jul 2006 BioProgress Announces Artificial Saliva Spray Registration
25 Jul 2006 TyRx Pharma, Inc., Announces FDA Clearance of PIVIT(TM) AB, a Novel Antimicrobial-Coated Surgical Mesh
20 Jul 2006 Seikagaku to Begin Clinical Trials of Injectable Hyaluronic Acid Gel for Knee Osteoarthritis Treatment in US
20 Jul 2006 Company to File for CE Mark for European Distribution in Late 2006; Presently Evaluating Potential Partners for European Commercialization
19 Jul 2006 Smith & Nephew Receives FDA Approval for EXOGEN 4000+* Bone Healing System
13 Jul 2006 Kensey Nash Receives FDA 510(k) Clearance for TriActiv FX(R) Embolic Protection System
11 Jul 2006 BioMimetic Therapeutics Successfully Completes Enrollment in Three Orthopedic Pilot Clinical Trials for GEM OS1(TM) Bone Graft; Canadian Study Expanded to 60 Patients
10 Jul 2006 OMRIX Biopharmaceuticals Receives FDA Approval for Second Generation Fibrin Sealant, Evicel(TM), For Use in Liver Surgery; Submits Evicel Phase III Study to FDA for Expanded Indication in Peripheral Vascular Surgery
06 Jul 2006 Uroplasty, Inc. Announces FDA Clearance for Their Next-Generation Device to Treat Overactive Bladder
05 Jul 2006 Cook Zilver Stent Receives FDA Approval for Vascular Use
05 Jul 2006 Medtronic Receives FDA Approval For Interstim® II System For Treatment Of Overactive Bladder, Urinary Retention
05 Jul 2006 Symphony Medical Announces Initiation of Phase II Multi-Center Clinical Trial for Biologic Therapy to Prevent Post-Operative Atrial Fibrillation
30 Jun 2006 Raymedica(R) Receives FDA Approval to Initiate Patient Enrollment in the HydraFlex(TM) Nucleus Arthroplasty System(TM) Clinical Trial
29 Jun 2006 MicroDose Technologies Announces Multi-Product Respiratory Collaboration for Its Next Generation Inhaler Device
28 Jun 2006 Medtronic Announces Completion of Patient Enrollment in ENDEAVOR IV Clinical Trial; Enrollment Also Complete in ENDEAVOR-Japan and RESOLUTE Clinical Studies
27 Jun 2006 Cardica Begins Pivotal Trial for PAS-Port(R) Proximal Anastomosis System for Use in Bypass Surgery
27 Jun 2006 ViaCell Finalizes IDE and Announces Plans to Commence Clinical Trial of ViaCyte in Oocyte Cryopreservation
27 Jun 2006 ev3 Receives FDA Clearance for SpideRX(TM) Embolic Protection Device for Saphenous Vein Graft Angioplasty
27 Jun 2006 Stryker Submits Application to FDA For Spinal Indication For OP-1 Putty
26 Jun 2006 IND Lodged with FDA for Clinical Trial of VivaGel for Genital Herpes
22 Jun 2006 Uroplasty's Next-Generation Device to Treat Overactive Bladder Awarded CE Marking
21 Jun 2006 SyntheMed Announces Positive Results From European Clinical Study for REPEL-CV(TM)
21 Jun 2006 MIV Therapeutics Details Exceptional Performance on HAp Coatings for Coronary Stents at Leading Biomedical Conference
 
<< Start < Prev 1 2 3 4 5 6 Next > End >>
Results 101 - 150 of 272

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Toll-Like Receptor (TLR) Agonists & Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics